Ausha P & C Industries to set up bulk drug unit at Ankleshwar in Bharuch in Gujarat with an investment of Rs. 5.0 million. The expansion details of the new unit are as follows.
| Sr. No. | Product Name | Capacity in MT/month |
| 1 | 7-Amino-3-(1-methyl-1-pyrolidinio)-methyl-ceph-3-em-4carboxylate (by two alternate processes) | 5.0 MT / month of any one individual product or combined production of all 24 products |
| 2 | Cefepime dihydrochloride monohydrate(Nonsterile) (by two alternate processes) | |
| 3 | 3,4-dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine Hydrochloride (by two alternate processes) | |
| 4 | 3,4-dimethoxy-N-[3-(4-methoxyphenyl)-1-methylpropyl]-B-phenylethylamine hydrochloride (by two alternate processes) | |
| 5 | 5-chloro-1-[1-[3-(2-oxo-1-benzimidazolinyl)propyl]-4-piperidyl]-2-benzimidazolinone technical | |
| 6 | 4-[1-oxo-4-[4-(hydroxy diphenylmethyl)-1-piperidinyl] butyl] alpha, alpha-dimethyl benzene acetic acid (by two alternate processes) | |
| 7 | 4-[1-hydroxy-4-[4-hydroxy diphenylmethyl)-1 -piperidinyl] butyl] alpha, alpha-dimethyl benzene acetic acid (by two alternate processes) | |
| 8 | 5-methoxyparatrifluoro methyl valerophenone (by two alternate processes) | |
| 9 | 5-methoxy-4`-(trifluoro methyl)valerophenone-[E] -O-(2-aminoethyl)-oxime (by two alternate processes) | |
| 10 | 2-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridine-2-yl methylthio] benzimidazole | |
| 11 | 2-hydroxymethyl-3-methyl- 4-(2,2,2-trifluoroethoxy) pyridine | |
| 12 | 4-(1,2,4-triazol-1-yl methyl)-benzonitrile | |
| 13 | 4-4`-(1H-1,2,4-triazol-1-yl methylene)-bis[benzonitrile] | |
| 14 | 1-[N2-(1-carboxy-3-phenyl propyl)-N6-(tert-butoxy carbonyl)L-lysyl)-L-proline | |
| 15 | 1,2,3,9-tetrahydro-9-methyl -3-[(2-methyl-1H- imidazol-1-yl)methyl]-4H-carbazol-4-one | |
| 16 | 2-dimethylaminomethyl cyclohexanone hydrochloride | |
| 17 | 2-[(dimethylamino)methyl] -1-(3-methoxyphenyl) cyclohexanol | |
| 18 | 4-(5-methyl-3-phenyl-4-isoxazolyl)-benzene sulfonamide | |
| 19 | N,N,6-Trimethyl-2-(4-methyl phenyl)-imidazo[1,2-a] pyridine-3 acetamide | |
| 20 | 2-(4-methyl phenyl)-6- methylimidazo[1,2-a] pyridine-3 acetonitrile | |
| 21 | 7-Amino-3-vinylcephalosporanic Acid | |
| 22 | Dibenzo [b,f] [1,4] thiazepine-(10H)-11-one | |
| 23 | 3,3-dimethyl-7-oxo-4-thio-1-azabiclo[3,2,0] heptane-2-carboxylic acid-4,4-dioxide | |
| 24 | 2-(1-piperazinylethoxy) ethanol |
Cardkem Pharma to expand its bulk drug unit at Ankleshwar in Bharuch district of Gujarat with an investment of Rs. 10 million.
| Sr
| Product | Production capacity in MT/month | ||
| Existing | Proposed | Total | ||
| 1 | PYRIDINE HYDROBROMIDE | 200.000 | -- | 200.000 |
| 2 | PHENYL ACETIC ACID | 3.000 | -- | 3.000 |
| 3 | PHOSPHOROUS TRIBROMIDE | 20.000 | -- | 20.000 |
| 4 | ACETYL BROMIDE | 5.000 | -- | 5.000 |
| 5 | PROPIONYL BROMIDE | 5.000 | -- | 5.000 |
| 6 | TRI PHENYL PHOSPHENE | 9.000 | -- | 9.000 |
| 7 | ETHYL TRIPHENYL PHOSPHONIUM BROMIDE | 5.000 | -- | 5.000 |
| 8 | PYRIDINIUM BROMIDE PERBROMIDE | 5.000 | -- | 5.000 |
| 9 | 4 HYDROXY CARBAZOLE | 6.000 | -- | 6.000 |
| 10 | N METHYL CARBAZALONE | 2.000 | -- | 2.000 |
| 11 | BROMO ACETIC ACID | 15.000 | -- | 15.000 |
| 12 | BROMO ACETYL BROMIDE | 5.000 | -- | 5.000 |
| 13 | DIBROMO ACETIC ACID | 5.000 | -- | 5.000 |
|
| BY PRODUCTS FROM EXISTING PRODUCTION |
|
|
|
| 14 | CETYL BROMIDE | 6.314 | -- | 6.314 |
| 15 | PHOSPHORIC ACID | 0.472 | -- | 0.472 |
| 16 | SULPHURIC ACID | 22.180 | -- | 22.180 |
| 17 | PHOSPHOROUS ACID | 4.140 | -- | 4.140 |
| 18 | LIQUOR AMMONIA | 4.380 | -- | 4.380 |
| 19 | ANILINE | 1.020 | -- | 1.020 |
| 20 | SODIUM BROMIDE | 21.230 | -- | 21.230 |
2. Proposed Products (Additional) with Production Capacity
| Sr
| Product
| Production capacity in MT/month | ||
| Existing | Proposed | Total | ||
| 1. | (Z)-2-(Tert-methoxy carbonyl-Methoxyimino)-2-(2-aminothiazol-4-yl) acetic acid (MICA acid) | Nil | 2.000 | 2.000 |
| 2. | S-2-benzothiazolyl(Z)-2-(2-aminothiazol-4-yl)-2-methoxy-carbonyl-methio acetate (MICA ester) | Nil | 4.000 | 4.000 |
| 3. | Cefotaxime Acid | Nil | 4.000 | 4.000 |
| 4. | Ceftriaxone Sodium | Nil | 2.000 | 2.000 |
| 5. | Chloramphenicol succinate | Nil | 5.000 | 5.000 |
| 6. | 6-hydroxy-3, 4-dihydro carbostyril | Nil | 2.000 | 2.000 |
| 7. | Dihydroxy ethyl ester | Nil | 2.000 | 2.000 |
| 8. | 2, 3 Dichlorobenzoyl cyanide | Nil | 2.000 | 2.000 |
| 9. | L -proline benzyl ester hydrochloride | Nil | 2.000 | 2.000 |
| 10. | 4-hydroxy-2-methyl-N-(5-methyl-2-thiozolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide | Nil | 2.000 | 2.000 |
| 11. | 5-Amino salicylic acid | Nil | 5.000 | 5.000 |
| 12. | Dibenzo [b,f] [1,4] thiazepine-(10H)-11-one | Nil | 2.000 | 2.000 |
| 13. | Valproic acid | Nil | 5.000 | 5.000 |
| 14. | 1-(2-amino-1-(4-methoxy phenyl) ethyl cyclohexanol | Nil | 2.000 | 2.000 |
| 15. | Chlorhexidine base (a) | Nil | 10.000 | 10.000 |
| Chlorhexidine base / and its salts (b) | Nil | |||
| 16. | Sodium 2-ethyl hexanoate | Nil | 25.000 | 25.000 |
| 17. | 7-[2-(2-amino-4-thiazolyl)-2(methylcarboxymethonylimino) acetamido]-3-vinyl-3-cephem-4-carboxyllic acid methyl ester | Nil | 5 MT of any individual product, and 15 MT combined production of all 11 products | 15.000 |
| 18. | 7-[2-(2-amino-4-thiazolyl)-2(methylcarboxymethonylimino) acetamido]-3-vinyl-4-carboxyllic acid trihydrate | Nil | ||
| 19. | 2,4-difluoro-2-(1H-4-amino-1,2,4-triazol-1-yl) acetophenone | Nil | ||
| 20. | 2,4-difluoro-2-(1H-1,2,4-triazol-1-yl) acetophenone | Nil | ||
| 21. | 4-(3,4 dichlorophenyl)-3,4-dihydronaphthalene-1-(2H)-one | Nil | ||
| 22. | 5 methylpyrazine 2- carboxyllic acid | Nil | ||
| 23. | 2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl) acetonitrile (b) | Nil | ||
| 2-(1-hydroxycyclohexyl)- 2-(4-methoxyphenyl) acetonitrile (a) | Nil | |||
| 24. | 2-amino-3-cyano-5-methylthiophene | Nil | ||
| 25. | 3-(2-chloro-6-fluoro phenyl)-5-methylisoxazole-4-carbonylchloride - FCMIC | Nil | ||
| 26. | 3-(2,6-dichlorophenyl)-5-methylisoxazole-4-carbonylchloride - DCMIC | Nil | ||
| 27. | 3-(2-chlorophenyl)-5-methylisoxazole-4-carbonylchloride - CMIC | Nil | 20.000 | 20.000 |
| 28. | HBr aqueous, 48% | Nil | 25 MT combined | 25.000 |
| 29. | HBr in acetic acid | Nil | ||
| 30. | Pyridine | Nil | 25.000 | 25.000 |
3. By Products
| Sr
| Product
| Production capacity in MT/month | ||
| Existing | Proposed | Total | ||
|
| By products from New products |
|
|
|
| 31. | sodium sulphate | Nil | 36.364 | 36.364 |
| 32. | HCl acid | Nil | 0.800 | 0.800 |
| 33. | phosphorous oxychloride | Nil | 1.490 | 1.490 |
| 34. | cuprous chloride | Nil | 1.143 | 1.143 |
| 35. | 2 - mercapto benzothiazole | Nil | 1.863 | 1.863 |
|
| TOTAL PRODUCTION (Existing + Proposed Additional) | 344.736 | 202.660 | 547.396 |
Cadila Pharmaceuticals to expand its bulk drugs unit at Ankleshwar in Bharuch district of Gujarat at its existing premises with an investment of Rs. 480 million. The expansion details of the new unit are as follows.
| Sl.No. | Name of Products | Type | Production Capacity (Kg/Month) | |
| Existing | Proposed | |||
| 1. | Erythromycin Stearate/Estolate I.P. | Bulk Drug | 1869 | - |
| 2. | Erythromycin Ethyl succinate USP | Bulk Drug | 290 | - |
| 3. | Nembutyle Ester | Bulk Drug | 1875 | - |
| 4. | Pentothal Acid | - do - | 540 | - |
| 5. | Pentothal sodium | - do - | 500 | - |
| 6. | Megaldrate | - do - | 3300 | - |
| 7. | Clarithromycin | - do - | 333 | - |
| 8. | Terazosin | - do - | 2 | - |
| 9. | Amlodipine Besylate | Bulk Drug & Intermediate | - | 2400 |
| 10. | Carvedilol | Bulk Drug & Intermediate | - | 700 |
| 11. | Celecoxib | - do - | - | 4400 |
| 12. | Chlorhexidine Acetate | - do - | - | 1730 |
| 13. | Chlorhexidine Base | - do - | - | 12000 |
| 14. | Chlorhexidine Gluconate | - do - | - | 156000 |
| 15. | Chlorhexidine HCL | - do - | - | 4950 |
| 16. | Cilostazone | - do - | - | 1080 |
| 17. | Desloratadine | - do - | - | 290 |
| 18. | Doxazocin Mesylate | - do - | - | 200 |
| 19. | Fluconazole | - do - | - | 200 |
| 20. | Fluoxetine HCI | - do - | - | 1310 |
| 21. | Glibenclamide | - do - | - | 2400 |
| 22. | Lacidipine | - do - | - | 30 |
| 23. | Losartan Potassium | - do - | - | 1000 |
| 24. | Loratadine | - do - | - | 900 |
| 25. | Meloxicam | - do - | - | 58 |
| 26. | Nebivolol | - do - | - | 72 |
| 27. | Olanzapine | - do - | - | 130 |
| 28. | Ondensatron | - do - | - | 100 |
| 29. | Pioglitazone | - do - | - | 1000 |
| 30 | Rabeprazole | - do - | - | 300 |
| 31. | Setraline HCI | - do - | - | 200 |
| 32. | Sildenafil Citrate | - do - | - | 300 |
| 33. | Venlafaxine | - do - | - | 750 |
| 34. | VF-2 HCI | - do - | - | 3000 |
| 35. | Zolpidem | - do - | - | 76 |
| 36. | Torasemide | - do - | - | 100 |
| 37. | Aripiprazole | - do - | - | 100 |
| 38. | Atorvastatine | - do - | - | 100 |
| 39. | Ezetimibe | - do - | - | 100 |
| 40. | Fexofenadine | - do - | - | 673 |
| 41. | Irbesartan | - do - | - | 500 |
| 42. | Itopride HCI | - do - | - | 508 |
| 43. | Olmesartan | - do - | - | 80 |
| 44. | Rabemipide | - do - | - | 80 |
| 45. | Nateglinide(CTD) | - do - | - | 665 |
| 46. | Ropinirole | - do - | - | 100 |
| 47. | Rupatidine | - do - | - | 160 |
| 48. | Telmisartan | - do - | - | 100 |
| 49. | Valsartan | - do - | - | 200 |
| 50. | Etambutol HCI | - do - | - | 1000 |
| Total | 8709 | 2,00,042 | ||
KDAC Chem to expand its bulk drug unit at Nandesari in Vadodara district in Gujarat with an investment of Rs. 45 million. The new bulk drug unit expansion details are as follows.
| S.N. | Products? name | Existing Products (MTPM) | Proposed New Products (MTPM) |
| 1 | Campholenic Aldehyde | 10.0 | - |
| 2 | Sandenol Capcore | 0.5 | - |
| 3 | Sandenol | 0.5 | - |
| 4 | Woodysol (By product) | 1.0 | - |
| 5 | Sodium Acetate Solution 30 % (By product) | 30.0 | - |
| 6 | Syrene Oxide | - | 100 |
| 7 | Phenyl Ethyl Alcohol | - | 100 |
| 8 | Phenyl Ethyl Methyl Ether | - | 10 |
| 9 | 2 Phenyl Ethyl Acetata | - | 50 |
| 10 | Allyl ISA Thio Cyanate | - | 5 |
| 11 | Ethyl Vaniline | - | 10 |
| 12 | Vaniline | - | 10 |
|
|
|
|
|
|
| 11,950 ₹ | 4950 ₹ | 4950 ₹ | 4950 ₹ | 3950 ₹ |
Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202 Mobile : 0-97898-37940 email : [email protected] Privacy Policy
